Ads
related to: drugs, herceptin- Treatment After Surgery
Explore Possible Treatment
Options For After Surgery.
- Treatment Before Surgery
Learn About Some Treatment
Options Used Before Surgery.
- Continuing Treatment
Get More Info About Continuing
Treatment After Surgery.
- Treatment Options Tool
Answer A Few Questions For Info To
Help Guide Your Doctor Discussions.
- Starting Treatment
See Possible Treatment Options
When Surgery Is The First Step.
- Download Discussion Guide
Find Helpful Questions To Get Your
Treatment Conversation Started.
- Treatment After Surgery
Search results
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe current standard of care in the first line is a combination of Genentech’s Herceptin...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 20 hours agoGets Under Your Skin Halozyme Therapeutics is an expert in drug delivery. The company is known for...
ASCO24: Can Ambrx’s novel ADC break into the metastatic breast cancer market?
Pharmaceutical Technology via Yahoo Finance· 4 days agoThis randomised trial, conducted across 85 centres in China, compared Ambrx Biopharma’s antibody-...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 4 days agoIn 2024, Teva expects Uzedy sales of approximately $80 million. Teva markets biosimilar versions of...
UCLA oncologist Dr. Dennis Slamon awarded Szent-Gy | Newswise
Newswise· 3 days agoDr. Dennis Slamon, a world-renowned oncologist and scientist whose groundbreaking research has...
Astra's Enhertu breast cancer trial shows 'unprecedented' results
Reuters via Yahoo News· 6 days agoThe findings, presented in Chicago at the annual meeting of the American Society of Clinical...
The Zacks Analyst Blog Highlights Roche, Wells Fargo, General Aerospace and Key Tronic
Zacks via Yahoo Finance· 3 days agoThe outlook for 2024 is ordinary as well. Competition from biosimilars for established cancer...
... Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07...
Benzinga· 6 days agoEvorpacept in combination with PADCEV®, an approved antibody-drug conjugate ("ADC"), demonstrated promising activity and was generally well toleratedCompany to host conference call and webcast with Samuel A. Funt,
Ads
related to: drugs, herceptin